-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, K9cIcnQMGsg5eruPSop2gj6Niqr6qqKSwoSXR7aX+iRjRUZj9SUotA1bMU7Rrg0B YxjrxvsnNuRktpXiNosbmg== 0001257957-06-000010.txt : 20060221 0001257957-06-000010.hdr.sgml : 20060220 20060221092611 ACCESSION NUMBER: 0001257957-06-000010 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060216 FILED AS OF DATE: 20060221 DATE AS OF CHANGE: 20060221 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVI BIOPHARMA INC CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE SW COLUMBIA STREET 2: STE 1105 CITY: PORTLAND STATE: OR ZIP: 97258 BUSINESS PHONE: 5032270554 MAIL ADDRESS: STREET 1: ONE SW COLUMBIA STREET 2: SUITE 1105 CITY: PORTLAND STATE: OR ZIP: 97258 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: IVERSEN PATRICK L CENTRAL INDEX KEY: 0001240570 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 06631336 BUSINESS ADDRESS: STREET 1: 4575 S.W RESEARCH WAY STREET 2: SUITE 200 CITY: CORVALLIS STATE: OR ZIP: 97333 BUSINESS PHONE: 5417533635 MAIL ADDRESS: STREET 1: 4575 S W RESEARCH WAY STREET 2: SUITE 200 CITY: CORVALLIS STATE: OR ZIP: 97333 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2006-02-16 0 0000873303 AVI BIOPHARMA INC AVII 0001240570 IVERSEN PATRICK L ONE SW COLUMBIA, SUITE 1105 PORTLAND OR 97258 1 1 0 0 Sr VP of Research & Devlopment Common Stock 44919 D Common Stock 3000 I by Spouse Common Stock 6000 I by Trust Incentive Stock Option (right to buy) 7.35 2006-02-16 4 A 0 23605 0 A 2007-02-16 2016-02-16 Common Stock 23605 23605 D Incentive Stock Option (right to buy) 7.35 2006-02-16 4 A 0 1000 0 A 2007-02-16 2011-02-16 Common Stock 1000 1000 I by Spouse Incentive Stock Option (right to buy) 7.35 2006-02-16 4 A 0 310 0 A 2006-02-16 2011-02-16 Common Stock 310 1310 I by Spouse Non-Qualified Stock Option (right to buy) 7.35 2006-02-16 4 A 0 51395 0 A 2007-02-16 2016-02-16 Common Stock 51395 51395 D Incentive Stock Option (right to buy) 2.53 2006-02-22 2015-02-22 Common Stock 75000 75000 D Incentive Stock Option (right to buy) 3.6875 2000-01-21 2009-01-21 Common Stock 14000 14000 D Incentive Stock Option (right to buy) 5.35 2004-12-05 2012-12-05 Common Stock 37382 37382 D Incentive Stock Option (right to buy) 5.75 2001-01-03 2010-01-03 Common Stock 25960 25960 D Incentive Stock Option (right to buy) 6.6875 1998-09-11 2007-09-01 Common Stock 59812 59812 D Incentive Stock Option (right to buy) 2.53 2005-07-15 2010-02-22 Common Stock 344 344 I by Spouse Non-Qualified Stock Option (right to buy) 3.6875 2000-01-21 2009-01-21 Common Stock 14000 14000 D Non-Qualified Stock Option (right to buy) 5.35 2003-12-05 2012-12-05 Common Stock 55018 55018 D Non-Qualified Stock Option (right to buy) 5.75 2001-01-03 2010-01-03 Common Stock 58040 58040 D Non-Qualified Stock Option (right to buy) 6.625 1999-01-01 2008-02-02 Common Stock 56000 56000 D Non-Qualified Stock Option (right to buy) 6.6875 1998-09-11 2007-09-01 Common Stock 40188 40188 D The Stock Option Grant vest as follows: 1/3 vest one year from date of grant and 1/3 each year thereafter until all shares vest three years from grant date. Grant vest 100% on grant date. Grant vest 100% at July 15, 2005. The amount of Securities Beneficially Owned include shares acquired through the Company's registered Employee Stock Purchase Plan. By: Mark M. Webber, Attorney-in-fact For: Patrick L. Iversen 2006-02-21 -----END PRIVACY-ENHANCED MESSAGE-----